Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - MELINTA THERAPEUTICS, INC. /NEW/ | d371888dex312.htm |
| 10-K/A - FORM 10-K/A - MELINTA THERAPEUTICS, INC. /NEW/ | d371888d10ka.htm |
Exhibit 31.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, David S. Zaccardelli, Pharm.D., certify that:
| (1) | I have reviewed this Amendment No. 1 to the annual report on Form 10-K for the year ended December 31, 2016 of Cempra, Inc.; |
| (2) | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Dated: April 13, 2017
| /s/ David S. Zaccardelli |
| David S. Zaccardelli, Pharm.D. |
| Acting Chief Executive Officer (Principal Executive Officer) |